Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF

被引：0
|
作者：
M Tanaka
T Yujiri
Y Tanaka
N Mitani
A Tanimura
Y Tanizawa
机构：
[1] Yamaguchi University Graduate School of Medicine,Department of Bio
[2] Yamaguchi University School of Medicine,Signal Analysis
来源：
Bone Marrow Transplantation | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1143 / 1144
页数：1
相关论文
共 50 条
  • [41] Serum levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand as markers of periprosthetic osteolysis
    Granchi, Donatella
    Pellacani, Andrea
    Spina, Mauro
    Cenni, Elisabetta
    Savarino, Lucia Maria
    Baldini, Nicola
    Giunti, Armando
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (07): : 1501 - 1509
  • [42] Receptor activator of nuclear factor-κB ligand (RANKL) as a novel prognostic marker in prostate carcinoma
    Perez-Martinez, Francisco C.
    Alonso, Veronica
    Sarasa, Jose L.
    Manzarbeitia, Felix
    Vela-Navarrete, Remigio
    Calahorra, Francisco J.
    Esbrit, Pedro
    HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (06) : 709 - 715
  • [43] Circulating levels of receptor activator of nuclear factor-κB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population
    Trofimov, S
    Pantsulaia, I
    Kobyliansky, E
    Livshits, G
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (03) : 305 - 311
  • [44] Cathepsin g enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-κB ligand
    Wilson, Thomas J.
    Nannuru, Kalyan C.
    Futakuchi, Mitsuru
    Sadanandam, Anguraj
    Singh, Rakesh K.
    CANCER RESEARCH, 2008, 68 (14) : 5803 - 5811
  • [45] Serum levels of receptor activator of nuclear factor κB ligand (RANKL) in healthy women and men
    Kerschan-Schindl, K.
    Wendlova, J.
    Kudlacek, S.
    Gleiss, A.
    Woloszczuk, W.
    Pietschmann, P.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (08) : 491 - 495
  • [46] Peripheral blood stem cells (Pbsc) mobilization and collection in healthy donors receiving granulocyte colony-stimulating factor (G-Csf) - A single-center experience about safety aspects
    Martino, M
    Morabito, F
    Pucci, G
    Console, G
    Messina, G
    Irrera, G
    Fujo, M
    Pontari, A
    Dattola, A
    Callea, I
    Ramirez, F
    Trimarchi, A
    Bresolin, G
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S108 - S108
  • [47] Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors
    Hilbe, W
    Nussbaumer, W
    Bonatti, H
    Thaler, J
    Niederwieser, D
    Nachbaur, D
    BONE MARROW TRANSPLANTATION, 2000, 26 (07) : 811 - 813
  • [48] Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors
    W Hilbe
    W Nussbaumer
    H Bonatti
    J Thaler
    D Niederwieser
    D Nachbaur
    Bone Marrow Transplantation, 2000, 26 : 811 - 813
  • [49] Cetylpyridinium Chloride Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Formation
    Zheng, Ting
    Chen, Ling
    Noh, A. Long Sae Mi
    Yim, Mijung
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (04) : 509 - 514
  • [50] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Its Relationship to Coronary Atherosclerosis in HIV Patients
    Hwang, Janice J.
    Wei, Jeffrey
    Abbara, Suhny
    Grinspoon, Steven K.
    Lo, Janet
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) : 359 - 363
12345